IGF1 and metabolic dysfunction-associated steatohepatitis: Subset analysis of patients presenting with NASH demonstrated lower mean serum IGF-1 levels than in those without NASH (115 ± 8 ng vs. 137 ± 8 ng, p = 0.02) [11].